Temasek Holdings (private) Limited - Net Worth and Insider Trading
Temasek Holdings (private) Limited Net Worth
The estimated net worth of Temasek Holdings (private) Limited is at least $8.4 Billion dollars as of 2025-06-06. Temasek Holdings (private) Limited is the 2201 Interest of corporation controlled by you of Innovent Biologics Inc and owns about 114,737,850 shares of Innovent Biologics Inc (HKSE:01801) stock worth over $8.4 Billion. Details can be seen in Temasek Holdings (private) Limited's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Temasek Holdings (private) Limited has not made any transactions after 2025-04-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Temasek Holdings (private) Limited
Temasek Holdings (private) Limited Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Temasek Holdings (private) Limited owns 1 companies in total, including Innovent Biologics Inc (HKSE:01801) .
Insider Ownership Summary of Temasek Holdings (private) Limited
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:01801 | Innovent Biologics Inc | 2025-04-29 |
Temasek Holdings (private) Limited Latest Holdings Summary
Temasek Holdings (private) Limited currently owns a total of 1 stock. Temasek Holdings (private) Limited owns 114,737,850 shares of Innovent Biologics Inc (HKSE:01801) as of April 25, 2025, with a value of $8.4 Billion.
Latest Holdings of Temasek Holdings (private) Limited
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:01801 | Innovent Biologics Inc | 2025-04-25 | 114,737,850 | 73.15 | 8,393,073,728 |
Holding Weightings of Temasek Holdings (private) Limited
Temasek Holdings (private) Limited Form 4 Trading Tracker
According to the SEC Form 4 filings, Temasek Holdings (private) Limited has made a total of 11 transactions in Innovent Biologics Inc (HKSE:01801) over the past 5 years, including 3 buys and 4 sells. The most-recent trade in Innovent Biologics Inc is the sale of 3,048,500 shares on April 25, 2025, which brought Temasek Holdings (private) Limited around $158 Million.
Insider Trading History of Temasek Holdings (private) Limited
- 1
Temasek Holdings (private) Limited Trading Performance
GuruFocus tracks the stock performance after each of Temasek Holdings (private) Limited's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Temasek Holdings (private) Limited is -9.89%. GuruFocus also compares Temasek Holdings (private) Limited's trading performance to market benchmark return within the same time period. The performance of stocks bought by Temasek Holdings (private) Limited within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Temasek Holdings (private) Limited's insider trading performs compared to the benchmark.
Performance of Temasek Holdings (private) Limited
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.08 | | | | | |
| Relative Return to S&P 500(%) | -5.16 | | | | | |
Temasek Holdings (private) Limited Ownership Network
Ownership Network List of Temasek Holdings (private) Limited
Ownership Network Relation of Temasek Holdings (private) Limited
Temasek Holdings (private) Limited Owned Company Details
What does Innovent Biologics Inc do?
Who are the key executives at Innovent Biologics Inc?
Temasek Holdings (private) Limited is the of Innovent Biologics Inc. Other key executives at Innovent Biologics Inc include 2101 Beneficial owner Yu De-chao Michael , 2502 Approved lending agent JPMorgan Chase & Co. , and 2201 Interest of corporation controlled by you The Capital Group Companies, Inc. .
Innovent Biologics Inc (HKSE:01801) Insider Trades Summary
Over the past 18 months, Temasek Holdings (private) Limited made 6 insider transaction in Innovent Biologics Inc (HKSE:01801) with a net sale of 6,533,500. Other recent insider transactions involving Innovent Biologics Inc (HKSE:01801) include a net purchase of 4,736,374 shares made by JPMorgan Chase & Co. , a net sale of 2,406,250 shares made by Yu De-chao Michael , and a net sale of 6,376,129 shares made by The Capital Group Companies, Inc. .
In summary, during the past 3 months, insiders sold 6,808,500 shares of Innovent Biologics Inc (HKSE:01801) in total and bought 0 shares, with a net sale of 6,808,500 shares. During the past 18 months, 18,753,155 shares of Innovent Biologics Inc (HKSE:01801) were sold and 8,173,650 shares were bought by its insiders, resulting in a net sale of 10,579,505 shares.
Innovent Biologics Inc (HKSE:01801)'s detailed insider trading history can be found in Insider Trading Tracker table.
Innovent Biologics Inc Insider Transactions
Temasek Holdings (private) Limited Mailing Address
Above is the net worth, insider trading, and ownership report for Temasek Holdings (private) Limited. Currently GuruFocus does not have mailing address information for Temasek Holdings (private) Limited.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
